Determination of free catecholamines in urine by tandem affinity/ion-pair chromatography and flow injection analysis.
BACKGROUND
A system was developed for the simultaneous measurement in urine of free catecholamines (i.e., dopamine, norepinephrine, epinephrine) and creatinine (i.e., an indicator of urine output and volume). This method was based on the use of tandem affinity/ion-pair HPLC and flow injection analysis.


METHODS
The free catecholamines were extracted directly from urine by using an on-line phenylboronic acid affinity column. The extracted solutes were then separated and measured by ion-pair chromatography followed by amperometric detection. Creatinine was measured by an on-line flow injection analysis system based on the Jaffe reaction, which analyzed creatinine as it eluted non-retained from the phenylboronic acid column.


RESULTS
Various factors were considered in the design and optimization of the phenylboronic acid column, the tandem affinity/ion-pair HPLC columns and the flow injection analysis system. The total analysis time for the final combined system was approximately 16 min per injection at 1 ml/min. This method was found to have good agreement with the expected results for control urine samples. The limits of detection for 20 microl samples (S/N=3.0) were 1.8, 1.0 and 4.3 microg/l for norepinephrine, epinephrine and dopamine, respectively, while the limit of detection of creatinine was 5.0 mg/l. The linear response of this method extended over a 450 to 930-fold range in concentration for the catecholamines and covered the range of clinical interest. The within-day precision of this method was +/-2.0-2.7%.


CONCLUSIONS
The ability of this method to simultaneously monitor both creatinine and other analytes makes this HPLC/FIA system an attractive method for use in monitoring urinary compounds. With this approach it was possible to provide fast results for small volumes of random urine samples that were collected as part of a psychological study. The same method could also be utilized with 12 or 24 h urine specimens.
Thomas
David H
DH
Department of Chemistry, University of Nebraska, Lincoln, NE, United States.
Taylor
Jay D
JD
Barnaby
Omar S
OS
Hage
David S
DS
D001897:Boronic Acids / Q000652:urine; D002395:Catecholamines / Q000652:urine*; D002846:Chromatography, Affinity; D002851:Chromatography, High Pressure Liquid; D003404:Creatinine / Q000652:urine; D004563:Electrochemistry; D017022:Flow Injection Analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D016014:Linear Models; D010316:Particle Size
D001897:Boronic Acids; D002395:Catecholamines; D003404:Creatinine; C010686:benzeneboronic acid
Clin Chem. 1999 May;45(5):593-615
10222345
Ann Clin Biochem. 2004 Jan;41(Pt 1):17-38
14713382
Anal Chem. 1994 Dec 1;66(23):4265-71
7847629
J Chromatogr A. 1997 Feb 21;762(1-2):97-112
9098970
Clin Chem. 1998 Aug;44(8 Pt 1):1759-62
9702972
J Pharm Biomed Anal. 2007 Apr 11;43(5):1673-81
17289328
J Neurosci Methods. 1985 May;13(3-4):239-48
4010333
Methods Enzymol. 1984;104:212-23
6371445
J Chromatogr. 1991 Jun 14;567(1):1-9
1918235
J Chromatogr A. 1994 May 27;669(1-2):9-19
8055106
Luminescence. 2006 Mar-Apr;21(2):112-7
16416506
Electrophoresis. 2007 Jun;28(12):1937-41
17480042
J Chromatogr A. 2004 Apr 2;1032(1-2):65-71
15065778
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Apr 25;818(2):269-76
15734169
J Anim Sci. 2000 Feb;78(2):420-8
10709934
Clin Chem. 1979 Feb;25(2):256-63
759019
World J Urol. 1999 Feb;17(1):35-9
10096149